Analysis of Inflammation and Microbiome in Patients With Sinusitis and Asthma
NCT02548598 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9
Last updated 2021-05-03
Summary
This is a cross-sectional, non-interventional study, consisting of three study arms, (1) Full Characterization (AIMS-Full), (2) Surgery Arm (AIMS-OR), and (3) Mucus Collection (AIMS-M). Participants will be recruited and enrolled in either AIMS-Full or AIMS-OR (based on participant availability). Participants who complete the initial characterization study (either AIMS-Full or AIMS-OR), may also go on to participate in the AIMS-M arm, which focuses mainly on sample collection. Participants who choose not to participate in either characterization arm are able to enroll directly into AIMS-M for sample collection only.
Conditions
- Asthma
- Chronic Rhinosinusitis
Interventions
- PROCEDURE
-
Endoscopic sinus surgery
This is an observational trial of patients with and without asthma who have concomitant chronic rhinosinusitis requiring endoscopic sinus surgery.
Sponsors & Collaborators
-
University of California, San Francisco
lead OTHER
Principal Investigators
-
John Fahy, MD, MSc · University of California, San Francisco
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-31
- Primary Completion
- 2017-09-30
- Completion
- 2021-04-30
Countries
- United States
Study Locations
More Related Trials
-
Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps
NCT05009758 ·Status: RECRUITING ·Phase: NA
-
Eosinophils Endotypes in Chronic Airway Inflammatory Diseases
NCT04187976 ·Status: COMPLETED
-
Blown Nasal Secretion Measurements in Rhinosinusitis: Repeatability and Validity Compared to Nasal Lavage
NCT00292851 ·Status: COMPLETED
-
Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment
NCT05642806 ·Status: RECRUITING ·Phase: PHASE4
-
Aggravated Airway Inflammation: Research on Genomics and Optimal Operative Treatment (AirGOs Operative)
NCT03704415 ·Status: COMPLETED ·Phase: NA
-
Preclinical Studies of Omalizumab in Chronic Rhinosinusitis With Nasal Polyposis
NCT04583501 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Predictive Factors in Chronic Rhinosinusitis With Nasal Polyps
NCT06459622 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Endotypic Stability in CRS
NCT06272123 ·Status: RECRUITING
-
The Role of IL5 in Epithelial Cell Integrity
NCT05895929 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Correlation Between the Microbiome and Type 2 Inflammatory Diseases of CRSwNP
NCT06231004 ·Status: NOT_YET_RECRUITING
-
Characterisation of the Nasal Microbiome in Patients With N-ERD
NCT04375293 ·Status: COMPLETED ·Phase: NA
-
Role of Epithelial Barrier Integrity in Biologic Treatment Response of Severe Asthmatics With/Out Chronic Rhinosinusitis With Nasal Polyps (CRSwNP).
NCT05365841 ·Status: RECRUITING
-
Nasal Microbiota Transfer Therapy in Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
NCT05400616 ·Status: RECRUITING ·Phase: NA
-
Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma
NCT06069310 ·Status: ACTIVE_NOT_RECRUITING
-
Endoscopic Sinus Surgery for Refractory Chronic Sinusitis
NCT02506426 ·Status: UNKNOWN ·Phase: NA
-
A Randomized Controlled Trial Evaluating Postoperative Debridement Following Endoscopic Sinus Surgery
NCT02154555 ·Status: COMPLETED ·Phase: NA
-
Immunologic Impact of Dupilumab in Patients Suffering From Asthma and Chronic Rhinosinusitis With Polyps
NCT06556264 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Nasal and Peripheral Blood Biomarkers of CRS Patients Before and After Surgical Intervention
NCT03250429 ·Status: COMPLETED
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Chronic Rhinosinusitis With Nasal Polyps
NCT02170337 ·Status: COMPLETED ·Phase: PHASE1
-
Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab)
NCT04823585 ·Status: COMPLETED ·Phase: PHASE4
-
Sinusitis in Children and the Nasopharyngeal Microbiome
NCT01492868 ·Status: COMPLETED
-
Effects of Allergic Rhinitis on the Nasal/Sinus Microbiome
NCT01461200 ·Status: COMPLETED
-
The Polymerase Chain Reaction (PCR) Analysis of Nasal Polyps for Fungal DNA
NCT00739921 ·Status: COMPLETED ·Phase: NA
-
Rhinosinusites Chroniques
NCT02407275 ·Status: UNKNOWN ·Phase: NA
-
Evolution of the Endonasal Microbiota in Patients With Chronic Rhinosinusitis
NCT04418622 ·Status: COMPLETED